Align Technology (ALGN) vs Zimmer Biomet (ZBH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Align Technology (ALGN) has outperformed Zimmer Biomet (ZBH) over the past year, gaining 6.0% versus a loss of 9.6%. Over five years, ZBH leads with a -37.5% price change compared with -76.1% for ALGN. Zimmer Biomet is the larger company by market cap ($16.97 billion vs $10.14 billion), about 1.7 times the size.
On valuation, Zimmer Biomet trades at a lower forward P/E (9.8x vs 11.5x for Align Technology). Zimmer Biomet pays a dividend yielding 1.08%, while Align Technology does not currently pay one. Align Technology converts more of its revenue into profit, with a net margin of 10.2% versus 8.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALGN | ZBH |
|---|---|---|
| Share price | $142.72 | $88.97 |
| Market cap | $10.14B | $16.97B |
| 1-day change | +1.20% | +0.10% |
| YTD return | -9.68% | -1.16% |
| 1-year return | +5.97% | -9.64% |
| 5-year return | -76.08% | -37.45% |
| P/E ratio (TTM) | 24.82 | 21.59 |
| Forward P/E | 11.46 | 9.81 |
| EPS (TTM) | $5.75 | $4.12 |
| Dividend yield | 0.00% | 1.08% |
| Annual dividend | $0.00 | $0.96 |
| Revenue (latest FY) | $4.03B | $8.23B |
| Revenue growth (YoY) | +0.90% | +7.20% |
| Net income (latest FY) | $410.35M | $705.10M |
| Gross margin | 67.19% | 69.71% |
| Operating margin | 13.53% | 13.34% |
| Net margin | 10.17% | 8.57% |
| 52-week high | $200.44 | $106.88 |
| 52-week low | $124.91 | $79.12 |
| Distance from 52-week high | -28.80% | -16.76% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +41.33% | +20.52% |
| Average volume | 900.35K | 2.17M |
| Shares outstanding | 71.04M | 190.74M |
| Employees | 20,435 | 17,000 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ALGN has outperformed ZBH by 15.6 percentage points over the past year.
- Zimmer Biomet offers a meaningfully higher dividend yield (1.08% vs 0.00%).
- Zimmer Biomet grew revenue faster in its latest fiscal year (+7.20% vs +0.90%).
About Align Technology
ALGN stock →Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
Health Care · Industrial Specialties · 20,435 employees
About Zimmer Biomet
ZBH stock →Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Health Care · Industrial Specialties · 17,000 employees
ALGN vs ZBH FAQ
Which is bigger, Align Technology or Zimmer Biomet?
Zimmer Biomet (ZBH) is larger, with a market capitalization of $16.97B compared with $10.14B for Align Technology (ALGN).
Which stock has performed better over the past year, ALGN or ZBH?
ALGN returned +5.97% over the past 12 months, compared with -9.64% for ZBH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ALGN or ZBH?
ZBH has the lower trailing P/E at 21.6, versus 24.8 for ALGN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Align Technology or Zimmer Biomet?
Zimmer Biomet pays a dividend yielding 1.08%, while Align Technology does not currently pay a regular dividend.
Are Align Technology and Zimmer Biomet in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.